Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
Frankfurt - Delayed Quote EUR

CureVac N.V. (5CV.F)

Compare
2.3460
-0.2240
(-8.72%)
At close: April 4 at 9:33:54 PM GMT+2
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
543,278
53,758
67,420
102,990
48,871
Cost of Revenue
157,940
124,366
183,993
238,195
14,173
Gross Profit
385,338
-70,608
-116,573
-135,205
34,698
Operating Expense
255,777
205,654
134,279
277,058
144,513
Operating Income
129,561
-276,262
-250,852
-412,263
-109,815
Net Non Operating Interest Income Expense
9,527
14,238
302
-235
-20,033
Other Income Expense
3,868
2,055
1,395
--
--
Pretax Income
142,954
-259,969
-249,155
-412,498
-129,848
Tax Provision
34,661
198
-126
-782
-726
Net Income Common Stockholders
108,294
-260,167
-249,029
-411,716
-129,122
Diluted NI Available to Com Stockholders
108,294
-260,167
-249,029
-411,716
-129,122
Basic EPS
0.48
-1.18
-1.32
-2.21
-0.72
Diluted EPS
0.47
-1.18
-1.32
-2.21
-0.72
Basic Average Shares
224,229.6780
220,833.2710
189,074.9110
186,012.5860
180,460.5650
Diluted Average Shares
225,032.3840
220,833.2710
189,074.9110
186,012.5860
180,460.5650
Total Operating Income as Reported
133,427
-274,207
-249,457
-412,263
-109,815
Total Expenses
413,717
330,020
318,272
515,253
158,686
Net Income from Continuing & Discontinued Operation
108,294
-260,167
-249,029
-411,716
-129,122
Normalized Income
105,363.8454
-261,913.7500
-250,423.2945
-411,716
-129,122
Interest Income
11,978
16,731
4,009
10,103
2,070
Interest Expense
2,451
2,493
3,707
10,338
22,103
Net Interest Income
9,527
14,238
302
-235
-20,033
EBIT
145,405
-257,476
-245,448
-402,160
-107,745
EBITDA
165,897
-234,090
-221,707
-386,486
-97,074
Reconciled Cost of Revenue
148,567
114,819
171,948
231,502
9,620
Reconciled Depreciation
20,492
23,386
23,741
15,674
10,671
Net Income from Continuing Operation Net Minority Interest
108,294
-260,167
-249,029
-411,716
-129,122
Total Unusual Items Excluding Goodwill
3,868
2,055
1,395
--
--
Total Unusual Items
3,868
2,055
1,395
--
--
Normalized EBITDA
162,029
-236,145
-223,102
-386,486
-97,074
Tax Rate for Calcs
0.0002
0.0002
0
0
0
Tax Effect of Unusual Items
937.8454
308.2500
0.7055
--
--
12/31/2020 - 8/14/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

0QF.F Moderna, Inc.
23.01
-6.22%
 
PHGN.BE Pharming Group
0.7150
-2.26%
 
RGO.SG Regeneron Pharmaceuticals Inc
524.00
-5.59%
 
MDG1.F Medigene AG
0.6680
+4.37%
 
FYB.F Formycon AG
22.35
-0.45%
 
MEDCL.PA MedinCell S.A.
13.38
-3.88%
 
22UA.F BioNTech SE
81.45
-1.27%
 
FYB.DE Formycon AG
22.90
+0.44%
 
ABVX.PA ABIVAX Société Anonyme
5.0000
-7.24%
 
MDG1.DE Medigene AG
0.6600
-6.25%